Viridian Therapeutics Inc. (1S1)
Market Closed
3 Jun, 20:00
XFRA 
€
13. 60
-0.9
-6.21%
€
- Market Cap
- P/E Ratio
- Div Yield
11 Volume
-4.96 Eps
€ 14.5
Previous Close Want to track 1S1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
1S1 Earnings Reports FAQ
What is the earnings per share (EPS) for 1S1?
The current EPS is -4.96.
What is the company's earnings growth rate?
Viridian Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Viridian Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Viridian Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 1S1 at this time, as Viridian Therapeutics Inc has no recent EPS data to calculate it.
